Literature DB >> 30335500

Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.

Carole L Wilson1, Sarah E Stephenson1, Jean Paul Higuero1, Carol Feghali-Bostwick2, Chi F Hung3, Lynn M Schnapp1.   

Abstract

Pericytes are key regulators of the microvasculature through their close interactions with the endothelium. However, pericytes play additional roles in tissue homeostasis and repair, in part by transitioning into myofibroblasts. Accumulation of myofibroblasts is a hallmark of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF). To understand the contribution and role of pericytes in human lung fibrosis, we isolated these cells from non-IPF control and IPF lung tissues based on expression of platelet-derived growth factor receptor-β (PDGFR-β), a common marker of pericytes. When cultured in a specialized growth medium, PDGFR-β+ cells retain the morphology and marker profile typical of pericytes. We found that IPF pericytes migrated more rapidly and invaded a basement membrane matrix more readily than control pericytes. Exposure of cells to transforming growth factor-β, a major fibrosis-inducing cytokine, increased expression of α-smooth muscle actin and extracellular matrix genes in both control and IPF pericytes. Given that pericytes are uniquely positioned in vivo to respond to danger signals of both systemic and tissue origin, we stimulated human lung pericytes with agonists having pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). Both control and IPF lung pericytes increased expression of proinflammatory chemokines in response to specific PAMPs and DAMPs released from necrotic cells. Our results suggest that control and IPF lung pericytes are poised to react to tissue damage, as well as microbial and fibrotic stimuli. However, IPF pericytes are primed for migration and matrix invasion, features that may contribute to the function of these cells in lung fibrosis.

Entities:  

Keywords:  fibrosis; human; immunity; lung; pericyte

Mesh:

Substances:

Year:  2018        PMID: 30335500      PMCID: PMC6337011          DOI: 10.1152/ajplung.00289.2018

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  48 in total

Review 1.  Pericytes and vascular stability.

Authors:  Desiree von Tell; Annika Armulik; Christer Betsholtz
Journal:  Exp Cell Res       Date:  2005-11-21       Impact factor: 3.905

2.  Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapy.

Authors:  Rebecca G Bagley; Cecile Rouleau; Sharon D Morgenbesser; William Weber; Brian P Cook; Srinivas Shankara; Stephen L Madden; Beverly A Teicher
Journal:  Microvasc Res       Date:  2006-04-19       Impact factor: 3.514

3.  Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts.

Authors:  Dimas T Covas; Rodrigo A Panepucci; Aparecida M Fontes; Wilson A Silva; Maristela D Orellana; Marcela C C Freitas; Luciano Neder; Anemari R D Santos; Luiz C Peres; Maria C Jamur; Marco A Zago
Journal:  Exp Hematol       Date:  2008-03-04       Impact factor: 3.084

4.  Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB.

Authors:  Abderahim Gaceb; Ilknur Özen; Thomas Padel; Marco Barbariga; Gesine Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-25       Impact factor: 6.200

5.  Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury.

Authors:  Irina A Leaf; Shunsaku Nakagawa; Bryce G Johnson; Jin Joo Cha; Kristen Mittelsteadt; Kevin M Guckian; Ivan G Gomez; William A Altemeier; Jeremy S Duffield
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

6.  Lung pericyte-like cells are functional interstitial immune sentinel cells.

Authors:  Chi F Hung; Kristen L Mittelsteadt; Rena Brauer; Bonnie L McKinney; Teal S Hallstrand; William C Parks; Peter Chen; Lynn M Schnapp; W Conrad Liles; Jeremy S Duffield; William A Altemeier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

7.  Cytokine production in lipopolysaccharide-exposed rat lung pericytes.

Authors:  David A Edelman; Yang Jiang; James G Tyburski; Robert F Wilson; Christopher P Steffes
Journal:  J Trauma       Date:  2007-01

8.  Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide.

Authors:  Andrej Kovac; Michelle A Erickson; William A Banks
Journal:  J Neuroinflammation       Date:  2011-10-13       Impact factor: 8.322

Review 9.  Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity.

Authors:  Rocío Navarro; Marta Compte; Luis Álvarez-Vallina; Laura Sanz
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

10.  Cultured pericytes from human brain show phenotypic and functional differences associated with differential CD90 expression.

Authors:  Thomas I-H Park; Vaughan Feisst; Anna E S Brooks; Justin Rustenhoven; Hector J Monzo; Sheryl X Feng; Edward W Mee; Peter S Bergin; Robyn Oldfield; E Scott Graham; Maurice A Curtis; Richard L M Faull; P Rod Dunbar; Mike Dragunow
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

View more
  9 in total

1.  Pericytes as novel targets for HIV/SIV infection in the lung.

Authors:  Sarah E Stephenson; Carole L Wilson; Nell G Bond; Amitinder Kaur; Xavier Alvarez; Cecily C Midkiff; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-09       Impact factor: 5.464

2.  A census of the lung: CellCards from LungMAP.

Authors:  Xin Sun; Anne-Karina Perl; Rongbo Li; Sheila M Bell; Eniko Sajti; Vladimir V Kalinichenko; Tanya V Kalin; Ravi S Misra; Hitesh Deshmukh; Geremy Clair; Jennifer Kyle; Laura E Crotty Alexander; Jorge A Masso-Silva; Joseph A Kitzmiller; Kathryn A Wikenheiser-Brokamp; Gail Deutsch; Minzhe Guo; Yina Du; Michael P Morley; Michael J Valdez; Haoze V Yu; Kang Jin; Eric E Bardes; Jarod A Zepp; Terren Neithamer; Maria C Basil; William J Zacharias; Jamie Verheyden; Randee Young; Gautam Bandyopadhyay; Sara Lin; Charles Ansong; Joshua Adkins; Nathan Salomonis; Bruce J Aronow; Yan Xu; Gloria Pryhuber; Jeff Whitsett; Edward E Morrisey
Journal:  Dev Cell       Date:  2021-12-21       Impact factor: 13.417

Review 3.  The Use of Quantitative Digital Pathology to Measure Proteoglycan and Glycosaminoglycan Expression and Accumulation in Healthy and Diseased Tissues.

Authors:  A Sally Davis; Mary Y Chang; Jourdan E Brune; Teal S Hallstrand; Brian Johnson; Sarah Lindhartsen; Stephen M Hewitt; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2020-09-16       Impact factor: 2.479

4.  MicroRNA-26b-5p Inhibits Mouse Liver Fibrogenesis and Angiogenesis by Targeting PDGF Receptor-Beta.

Authors:  Le Yang; Chengbin Dong; Jingjing Yang; Lin Yang; Na Chang; Changbo Qi; Liying Li
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-26

Review 5.  New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy.

Authors:  Eloisa Romano; Irene Rosa; Bianca Saveria Fioretto; Marco Matucci-Cerinic; Mirko Manetti
Journal:  Life (Basel)       Date:  2021-06-24

Review 6.  Expression and function of PDGF-C in development and stem cells.

Authors:  Yi Tian; Ying Zhan; Qin Jiang; Weisi Lu; Xuri Li
Journal:  Open Biol       Date:  2021-12-01       Impact factor: 6.411

Review 7.  Advancing brain barriers RNA sequencing: guidelines from experimental design to publication.

Authors:  David M F Francisco; Luca Marchetti; Sabela Rodríguez-Lorenzo; Eduardo Frías-Anaya; Ricardo M Figueiredo; Peter Winter; Ignacio Andres Romero; Helga E de Vries; Britta Engelhardt; Rémy Bruggmann
Journal:  Fluids Barriers CNS       Date:  2020-08-18

Review 8.  Are Liver Pericytes Just Precursors of Myofibroblasts in Hepatic Diseases? Insights from the Crosstalk between Perivascular and Inflammatory Cells in Liver Injury and Repair.

Authors:  Lindolfo da Silva Meirelles; Renan Fava Marson; Maria Inês Gonzalez Solari; Nance Beyer Nardi
Journal:  Cells       Date:  2020-01-11       Impact factor: 6.600

9.  Pulmonary fibrosis: something old, something new…still waiting for a breakthrough.

Authors:  Carol Feghali-Bostwick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 5.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.